CORTENDO INVEST AB has a total of 19 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Canada, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals are METABOLIC PHARMACEUTICALS PTY LTD, PILKIEWICZ FRANK G and NATUMIN PHARMA AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Israel | 2 | |
#4 | Republic of Korea | 2 | |
#5 | United States | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | Hong Kong | 1 | |
#10 | Norway | 1 | |
#11 | New Zealand | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Stewart Timothy Andrew | 6 |
#2 | Maerin Per | 5 |
#3 | Stewart Tim | 3 |
#4 | Marin Per | 3 |
Publication | Filing date | Title |
---|---|---|
AU2007237899A1 | Methods and compositions for treating barth syndrome, cardiomyopathy, mitochondrial diseases and other conditions | |
CA2594433A1 | Compositions comprising the 2s,4r ketoconazole enantiomer for treating diabetes, metabolic syndrome and other conditions |